Recent Confirmed OrdersLast 7 days
Australia520 mgTirzepatide 40 mg · Semaglutide 2 mg · Dihexa 10 mg
View all

Laboratory ancillaries

Acetic Acid Water

Dilute aqueous acetic acid · laboratory process auxiliary

Per released-lot specification · target, verify batch COACAS 64-19-7RUO
Research statusFormulation- and lot-defined laboratory ancillary
Supplied formAqueous small-molecule mixture (non-peptide laboratory ancillary)
Lead time7–14 days
Acetic Acid Water — Clear, colorless liquid when specified; confirm released-lot appearance on the COA
Acetic Acid Water — Clear, colorless liquid when specified; confirm released-lot appearance on the COA · Representative packaging image · verify the ordered lot
Representative packaging image · verify the ordered lot

Decision summary

Key benefits

  • Potential laboratory roles include pH adjustment, solubility screening and process-method development
  • Whether an acidic medium improves or reduces solubility, stability, metal coordination or assay performance is analyte- and matrix-specific and must be demonstrated experimentally.
Published research context is presented for literature orientation only. It is not a dosing, treatment or human-use instruction.

Qualification data

Specifications to confirm against the released lot

CAS
64-19-7
Formula
Not applicable — aqueous mixture; acetic acid component C2H4O2
Molecular weight
Component-specific; no single molecular weight
Appearance
Clear, colorless liquid when specified; confirm released-lot appearance on the COA
Purity
Per released-lot specification · target, verify batch COA
Storage
Store according to the released-lot COA, SDS and container-closure stability statement. Do not apply a universal room-temperature, refrigeration or open-container hold time; supported conditions depend on concentration, water grade, preservative status, container and microbial controls.
MOQ
On request
Lead time
7–14 days

Qualification matrix

Identity, purity and content are separate release questions.

Identity

Confirm the stated molecule and supplied form. Start with the matching batch COA; request sequence-level evidence only when the buyer's written procedure requires it and availability or a separate scope has been agreed.

Purity

Review RP-HPLC method conditions, wavelength, integration and related-peak handling. A percentage without the method is not enough.

Content

Net peptide content is not the same as gross lyophilized powder weight. Ask which assay supports the stated amount and whether water/counter-ion is addressed.

Stability

Define long-term storage and transit exposure separately. Cold-chain can be quoted when the buyer’s risk assessment requires it and adds cost.

Research context

What researchers study about Acetic Acid Water

Acetic Acid Water is a commercial or laboratory name for dilute aqueous acetic acid, not a single compendial composition. The name alone does not define concentration, pH, water grade, sterility, endotoxin, preservative content or container system. It may be evaluated as an acidic process medium in solubility or formulation studies, but every attribute relevant to a controlled workflow must be specified and verified for the released lot.

  • Laboratory pH adjustment, analyte-specific solubility screening and formulation or analytical method development
  • No therapeutic indication or administration use is claimed.

Mechanism context

The question the literature is testing

Acetic acid is a weak acid that changes proton activity and the ionization state of ionizable groups in water. This can alter apparent solubility, aggregation, adsorption, metal coordination and degradation pathways. Peptide formulation reviews emphasize that pH, ionic strength, sequence, counterion and container can affect both solubility and stability; acid exposure can improve one attribute while worsening another. Method selection therefore requires analyte-specific evidence and controlled pH measurement.

Evidence map

Research routes and exposure context

Evidence tierAnalytical / laboratory context
Routes reported in sources
No administration route applies
Dose / exposure contextProtocol-specific; verify the cited primary source
Routes and exposure contexts summarize cited studies or approved finished-product labels. They are not instructions for administering this RUO material; no customer dose is provided.

Evidence boundaries

Compatibility, limitations and decision context

  • For qualified laboratory research only
  • Hazards depend on the actual acetic-acid concentration and specification; consult the released-lot SDS
  • The product is not established as sterile, injectable grade or suitable for human or veterinary administration unless those attributes are separately defined and supported by validated lot-specific evidence.

Interactions reported in the literature

  • Compatibility depends on analyte sequence, concentration, counterions, buffers, metals, preservatives, container surfaces and the downstream method
  • Do not adopt universal peptide lists or prescriptive mixing instructions without formulation-specific evidence.
Literature context is not a supplier release result or human-use instruction. Follow your institution's approved laboratory risk assessment.

Factory batch documentation

Acetic Acid Water factory batch COAs

Representative records, refreshed periodically

Published COAs show representative factory batches and may not be the latest available. For a current quote or shipment, our sales team can confirm the applicable lot and provide its COA.

Independent testing, arranged on request

Third-party reports are not routinely published. If independent verification is required, we can agree the laboratory, method, acceptance criteria and remedy before testing. If the agreed specification is not met, an appropriate resolution—including a refund where applicable—can be discussed under the agreed terms. Unless otherwise agreed in writing, the buyer pays the cost of this optional testing.

Help reviewing your COA

Need help reading a factory COA or third-party report? Our sales team can clarify test items, specifications and how the results relate to the lot under discussion.

Ask for the current packet, not a generic certificate

  • Qualify acetic-acid identity and quantitative assay, concentration expression and units, pH, water grade, impurity profile, preservative status, fill volume, container closure, storage and supported hold time
  • Where the process requires them, add validated bioburden, endotoxin or sterility tests
  • Appearance alone and a generic COA are insufficient.
Released-batch COARP-HPLC result and method contextIdentity result appropriate to the moleculeWater / counter-ion context where relevantSDS and handling statementAdditional testing scoped on request

Available fills

Quote the fill and pack configuration you need

Reference SKUFillBase pack
AAW-03ML3 ml10 vials
AAW-05ML5 ml10 vials
AAW-10ML10 ml10 vials

Handling

Storage in the lab and temperature during transit are different decisions

Store according to the released-lot COA, SDS and container-closure stability statement. Do not apply a universal room-temperature, refrigeration or open-container hold time; supported conditions depend on concentration, water grade, preservative status, container and microbial controls.

State destination, season, acceptable transit exposure and whether your protocol requires insulated or cold-chain service. Additional temperature-control cost is quoted explicitly.

Buyer FAQ

Terms to settle before the purchase order

Can a buyer arrange third-party testing?+

Yes. Testing must be performed by a mutually accepted, established specialist laboratory. Fee allocation, specification, sampling, method and acceptance rule must be agreed before testing; if an agreed independent result shows nonconformance, the remedy follows the signed order terms. Unless otherwise agreed in writing, the buyer pays the cost of this optional testing.

Does HPLC purity prove peptide content?+

No. Chromatographic purity describes the relative peak profile under a stated method. Identity, water, counter-ion, residual solvents and assay/content may require separate methods.

Is cold-chain shipping always required?+

Not always. Heat can accelerate degradation, especially during summer and long transit. Cold-chain reduces exposure but raises cost. State the destination and stability risk so the right service can be quoted.

How are payment terms handled?+

Available methods and milestones depend on order value, destination and project type. The pro forma invoice should state currency, bank details, fees, payment milestones and the release condition.

Why must the testing laboratory understand peptide chemistry?+

Free-base and salt forms, hydrophilic and hydrophobic sequences, aggregation and adsorption can change sample preparation and method suitability. Use a laboratory experienced with the molecule class.

These are buyer-qualification references, not claims that this RUO material is regulated, certified or released under those frameworks. Applicability depends on the buyer's workflow and jurisdiction.

Selected sources

Literature behind the research context

  • Chemical identity: NIH PubChem CID 176 and NIST Chemistry WebBook CAS 64-19-7 report C₂H₄O₂ and molecular weight 60.05 g/mol or 60.0520 for the acetic acid component; these records do not define the composition of this aqueous product.
  • Peptide formulation context: Bak et al., AAPS J. 2015, PMID 25398427 and PMCID PMC4287299, explains that peptide solubility and stability can both depend strongly on pH, ionic strength, counterion and container.
  • Research-peptide handling context: Hoofnagle et al., Clin Chem. 2016, PMID 26719571 and PMCID PMC4830481, recommends sequence-aware solubilization and control of adsorption, concentration, container and storage for peptide assay standards.
  • Compendial boundary: the USP-NF Acetic Acid Irrigation monograph describes a different sterile formulation and concentration. It is useful as a quality-system precedent but does not establish this product's composition, sterility, endotoxin result or suitability.
  1. 01

    Physicochemical and Formulation Developability Assessment for Therapeutic Peptide Delivery—A Primer

    The AAPS Journal · 2015 · peer-reviewed review

    Open source
  2. 02

    Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry-Based Assays

    Clinical Chemistry · 2016 · peer-reviewed consensus recommendations

    Open source
  3. 03

    Acetic Acid — PubChem CID 176

    NIH PubChem · 2026 · authoritative public chemical database

    Open source
  4. 04

    Acetic acid

    NIST Chemistry WebBook, SRD 69 · 2026 · government standard reference database

    Open source
  5. 05

    Acetic Acid Irrigation

    USP-NF · 2024 · pharmacopeial monograph preview

    Open source

Product FAQ

Questions buyers ask about Acetic Acid Water

Does 'Acetic Acid Water' define one standard composition?+

No. The market name can refer to aqueous acetic-acid solutions with different concentration expressions, pH targets, grades, preservatives, containers and test packages. Confirm the acetic-acid concentration and units, water grade, pH specification, preservative status, fill volume and actual COA tests for the ordered lot; do not infer a universal 0.6% or pH 3.0–3.5 specification from the name.

When can an acidic aqueous medium help a peptide-solubility study?+

Lowering pH can change ionization, apparent solubility, aggregation and adsorption, but the direction and magnitude depend on the peptide sequence, isoelectric point, concentration, counterions, buffer capacity, container and analytical endpoint. Screen a small matrix range using a cited method or formulation study for the specific analyte; acidic water is not a universal replacement for saline, buffer or another validated diluent.

What documentation is needed before using a lot in a controlled workflow?+

Agree the specification before ordering: identity and quantitative assay of acetic acid, concentration units, pH, water quality, impurities, preservative status, container closure, storage and supported hold time. Add bioburden, endotoxin or sterility testing only when the workflow requires it and when validated, lot-specific reports are available. A clear appearance or generic COA does not establish injectable grade or sterile-process suitability.